Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Toshiharu, Fujii"'
Autor:
Toshiharu Fujii, Yuji Ikari
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 9, p 256 (2024)
The study assessed the epidemiological frequency and prognostic impact of new-onset cancer as an additional net adverse clinical outcome in patients after ST-elevation myocardial infarction (STEMI), considering its potential clinical significance alo
Externí odkaz:
https://doaj.org/article/57fcc2d870164df18c157599caf7b936
Autor:
Dongfeng Zhang, Xiantao Song, Sergio Raposeiras-Roubín, Emad Abu-Assi, Jose Paulo Simao Henriques, Fabrizio D’Ascenzo, Jorge Saucedo, José Ramón González-Juanatey, Stephen B. Wilton, Wouter J. Kikkert, Iván Nuñez-Gil, Albert Ariza-Sole, Dimitrios Alexopoulos, Christoph Liebetrau, Tetsuma Kawaji, Claudio Moretti, Zenon Huczek, Shaoping Nie, Toshiharu Fujii, Luis Correia, Masa-aki Kawashiri, Danielle Southern, Oliver Kalpak
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Background: Treatment of acute myocardial infarction (AMI) patients with prior stroke is a common clinical dilemma. Currently, the application of optimal medical therapy (OMT) and its impact on clinical outcomes are not clear in this patient populati
Externí odkaz:
https://doaj.org/article/1ed66cc14044431b9d2c3eb3e54f796c
Autor:
Toshiharu Fujii, Yuji Ikari
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 9, p1191-1196, 6p
Publikováno v:
International Journal of Emergency Medicine, Vol 12, Iss 1, Pp 1-10 (2019)
Abstract Background Early discrimination of ST-elevation myocardial infarction (STEMI) due to a left main trunk (LMT) lesion provided by straightforward electrocardiographic criteria is useful for prompt treatment. The purpose of this study is to inv
Externí odkaz:
https://doaj.org/article/cc935f17a2064fbe80a2f758d5ec32c6
Autor:
Toshiharu Fujii, Shiori Endo, Ryo Tsuchiya, Hirofumi Nagamatsu, Satoshi Kasai, Yota Kawamura, Fuminobu Yoshimachi, Yuji Ikari
Publikováno v:
International Journal of Cardiology. 375:1-6
Autor:
Ryuichi Tamimoto1,2, Toshiharu Fujii2,3, Hirofumi Nagamatsu2,3, Tsutomu Murakami2,3, Koji Miyazaki2,4, Shinya Goto3, Yasunori Cho1, Hidezo Mori1,2,5 hidezomori@hotmail.com
Publikováno v:
Systematic Reviews in Pharmacy. 2022, Vol. 13 Issue 6, p631-635. 5p.
BackgroundThis study estimates the temporal risk variations of ischemic and bleeding events during dual antiplatelet therapy (DAPT) and suggests the optimal period for DAPT after acute coronary syndrome (ACS) categorized by the Academic Research Cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99dfeb17b608910192c3c2c52c713ba1
https://doi.org/10.1101/2023.04.25.23289123
https://doi.org/10.1101/2023.04.25.23289123
Autor:
Koji Miyazaki, Toshiharu Fujii, Kikue Mori, Ryuichi Tamimoto, Hirofumi Nagamatsu, Tsutomui Murakam, Yasunori Cho, Shinya Goto, Hidezo Mori
We recently reported that sub-acute myocarditis occurred following the initial two doses of mRNA-based vaccination against COVID-19 (0.3 mL Comirnaty®) in elderly Japanese patients with cardiac dysfunction. The present retrospective study of 76 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a7f57d1a3a4e5b2fd020def87f67db8
https://doi.org/10.21203/rs.3.rs-2117240/v1
https://doi.org/10.21203/rs.3.rs-2117240/v1
Autor:
Toshiharu Fujii
Publikováno v:
International Journal of Cardiology. 381:1
Autor:
Sergio Raposeiras-Roubín, José Ramón González Juanatey, Gaetano M. De Ferrari, José P.S. Henriques, Laura Montagna, Iván J. Núñez-Gil, Tim Kinnaird, Lazar Velicki, Alessandro Durante, Shaoping Nie, Tetsuma Kawaji, Ferdinando Varbella, Xiantao Song, Matteo Bianco, Masa-aki Kawashiri, Alicia Quirós, Fabrizio D'Ascenzo, Umberto Morbiducci, Christoph Liebetrau, Fabrizio Ugo, Alessia Luciano, Stephen B. Wilton, Alessandro Careggio, Paola Destefanis, Amanda Spirito, Enrico Cerrato, Dimitrios Alexopoulos, Carlo Alberto Biolè, Giacomo Boccuzzi, Toshiharu Fujii, Emad Abu-Assi, Zenon Huczek, Alberto Dominguez-Rodriguez, Giorgio Quadri, Sergio Manzano-Fernández, Luis C. L. Correia, Andrea Rognoni, Christian Templin, Albert Ariza-Solé
Publikováno v:
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, 35(6), 1171-1182. Kluwer Academic Publishers
Purpose: Higher risk of bleeding with ticagrelor over clopidogrel in elderly patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI) has been suggested. We assessed the incidence of major bleedings (MB), rei